Strain name |
Strain Background |
Target gene/Cre type |
Application Notes |
B6.Cg-Tg(Alb-cre)21Mgn/J |
C57BL/6 |
Alb (albumin promoter drives Cre) |
Liver-specific gene knockout for studying metabolic diseases, liver cancer, or drug hepatotoxicity. |
B6.Cg-Tg(Nes-cre)1Kln/J |
C57BL/6 |
Nestin (Neural Stem Cell/Progenitor Cell Cre) |
Central nervous system (neurons, glial cells) conditional knockout for neurodevelopmental or degenerative disease research. |
B6.129S4-Cd19tm1(cre)Cgn/J |
C57BL/6 × 129S4 |
CD19 (B cell-specific Cre) |
B cell gene knockout to study antibody production, autoimmune disease, or lymphoma. |
B6.Cg-Tg(Myh6-cre/ERT2)1Jmk/J |
C57BL/6 |
Myh6 (α-myosin heavy chain, tamoxifen-inducible Cre) |
Cardiomyocyte-specific inducible knockout for use in cardiac regeneration or heart failure models. |
B6;129S-Tg(Vil1-cre)997Gum/J |
C57BL/6 × 129S |
Vil1 (intestinal epithelial cell-specific Cre) |
Intestinal epithelial gene knockout for inflammatory bowel disease (IBD) or gut microbiota interaction studies. |
B6.Cg-Tg(Tek-cre)1Ywa/J |
C57BL/6 |
Tek (Tie2, Endothelial Cre) |
Conditional knockout of endothelial cells to study angiogenesis, tumor vascularization, or atherosclerosis. |
B6.Cg-Tg(Camk2a-cre)T29-1Stl/J |
C57BL/6 |
Camk2a (forebrain neuron-specific Cre) |
Gene knockout of excitatory neurons (such as hippocampus and cortex) is used to study learning and memory or epilepsy mechanisms. |
B6.129P2-Lyz2tm1(cre)Ifo/J |
C57BL/6 × 129P2 |
Lyz2 (lysozyme, myeloid cell Cre) |
Specific knockout of macrophages and neutrophils for infection immunity or tumor microenvironment research. |
B6.Cg-Tg(Sox2-cre)1Amc/J |
C57BL/6 |
Sox2 (Epithelial Stem Cell Cre) |
Gene knockout of epithelial stem cells in the skin, lung, intestine, etc. to study tissue regeneration or cancer stem cells. |
B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J |
C57BL/6 |
UBC (ubiquitin C promoter, tamoxifen-inducible Cre) |
Systemic knockout (requires crossing with floxed mice) is used to study gene function in adult animals. |
B6;129S-Gt(ROSA)26Sortm1(cre/ERT2)Tmj/J |
C57BL/6 × 129S |
ROSA26 (tamoxifen-inducible Cre) |
Systemic controllable knockout, suitable for multi-tissue gene function research (needs to be used in combination with tissue-specific promoters). |
B6;129S6-Chattm1(cre)Lowl/J |
C57BL/6 × 129S6 |
ChAT (Choline Acetyltransferase, Cholinergic Neuron Cre) |
Cholinergic neuron-specific knockout for Alzheimer's disease or autonomic nervous system function research. |
Strain name |
Strain Background |
Target Gene |
Application Notes |
B6.129S2-Trp53tm1Tyj/J |
C57BL/6 × 129S2 |
Trp53 (p53) |
Spontaneous lymphoma, sarcoma (6-12 months old), increased tumor susceptibility. Cancer occurrence mechanism, chemotherapy drug screening |
B6.129P2-Apoetm1Unc/J |
C57BL/6 × 129P2 |
ApoE (Apolipoprotein E) |
High-fat diet induces atherosclerotic plaques (12-16 weeks) and lipid metabolism disorders. Cardiovascular disease, Alzheimer's disease |
B6.129S1-Il10tm1Cgn/J |
C57BL/6 × 129S1 |
IL-10 |
Spontaneous colitis (3-6 months of age), immune dysregulation. Inflammatory bowel disease (IBD), immune tolerance |
B6.129S4-Cd19tm1(cre)Cgn/J |
C57BL/6 × 129S4 |
CD19 |
B cell development is blocked, there are no mature B cells, and humoral immunity is defective. B cell function, autoimmune disease |
B6.Cg-Lepob/J |
C57BL/6 |
Leptin |
Obesity, hyperglycemia, insulin resistance (from 4 weeks of age), metabolic syndrome phenotype. Research on the mechanism of type 2 diabetes and obesity |
B6.129S7-Rag1tm1Mom/J |
C57BL/6 × 129S7 |
Rag1 |
T/B lymphocyte deficiency, severe combined immunodeficiency (SCID). Immune reconstruction, humanized tumor transplantation (PDX) |
B6.129S-Tg(APP)Swe/J |
C57BL/6 × 129S |
APP (Swedish mutation) |
Overexpression of Aβ, the appearance of amyloid plaques at 6 months of age, and cognitive decline. Pathological mechanism of Alzheimer's disease |
B6.129S-Tg(SOD1)G93A/J |
C57BL/6 × 129S |
SOD1 (G93A mutation) |
Motor neuron degeneration and hind limb paralysis (3-4 months of age) mimics amyotrophic lateral sclerosis (ALS). |
B6.129S2-Ins2tm1Tyj/J |
C57BL/6 × 129S2 |
Ins2 (Insulin 2) |
Postnatal hyperglycemia, β-cell failure, simulating type 1 diabetes. Diabetes mechanism, islet transplantation research |
B6.129S4-Gt(ROSA)26Sortm1Hjf/J |
C57BL/6 × 129S4 |
ROSA26 (LacZ reporter) |
Systemic LacZ expression for tracking gene knock-in or cell lineage. Reporter gene system, cell fate mapping |
Strain name |
Strain Background |
Cre type/promoter |
Target cells/tissues |
Application Scenario |
B6.Cg-Tg(CMV-cre)1Cgn/J |
C57BL/6 |
Cre driven by the constitutive CMV promoter |
Widely expressed throughout the body |
Basic research (needs to be crossed with floxed mice to achieve systemic knockout), but may result in missed cuts or embryonic lethality. |
B6.Cg-Tg(Sox2-cre)1Amc/J |
C57BL/6 |
Sox2 (Epithelial Stem Cell Cre) |
Epithelial stem cells such as skin, lung, and intestine |
Study tissue regeneration, epithelial carcinogenesis or stem cell function. |
B6.Cg-Tg(Alb-cre)21Mgn/J |
C57BL/6 |
Alb (albumin promoter drives Cre) |
Hepatocytes |
Liver-specific genetic manipulation (e.g. liver cancer models, metabolic diseases). |
B6;129S-Gt(ROSA)26Sortm1(cre/ERT2)Tmj/J |
C57BL/6 × 129S |
Insertion of tamoxifen-inducible Cre-ERT2 at the ROSA26 locus |
Systemically controllable (requires tamoxifen induction) |
Temporally and spatially specific gene knockout in adult animals avoids developmental lethal effects. |
B6.Cg-Tg(Nes-cre)1Kln/J |
C57BL/6 |
Nestin (Neural Stem Cell/Progenitor Cell Cre) |
Central nervous system (neurons, glial cells) |
Neurodevelopmental, glioma, or neurodegenerative disease research. |
B6.Cg-Tg(Myh6-cre/ERT2)1Jmk/J |
C57BL/6 |
Myh6 (α-myosin heavy chain, inducible Cre) |
Cardiomyocytes |
Cardiac disease models (e.g., post-myocardial infarction repair, myocardial fibrosis). |
B6.129S4-Cd19tm1(cre)Cgn/J |
C57BL/6 × 129S4 |
CD19 (B cell-specific Cre) |
B lymphocytes |
Research on immune response, B-cell lymphoma or autoantibody related diseases. |
B6.Cg-Tg(Tek-cre)1Ywa/J |
C57BL/6 |
Tek (Tie2, Endothelial Cre) |
Endothelial cells |
Angiogenesis, tumor vascularization or atherosclerosis research. |
B6.Cg-Tg(Lyz2-cre)1Ifo/J |
C57BL/6 |
Lyz2 (lysozyme, myeloid cell Cre) |
Macrophages, neutrophils |
Research on infection immunity and tumor-associated macrophage (TAM) function. |
B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J |
C57BL/6 |
Ubiquitin C promoter drives tamoxifen-inducible Cre |
Systemic induction (requires tamoxifen) |
Study the function of genes in adulthood (avoiding interference during development). |